You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLOMIPHENE CITRATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Clomiphene Citrate patents expire, and what generic alternatives are available?

Clomiphene Citrate is a drug marketed by Cosette and is included in one NDA.

The generic ingredient in CLOMIPHENE CITRATE is clomiphene citrate. There are sixteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the clomiphene citrate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Clomiphene Citrate

A generic version of CLOMIPHENE CITRATE was approved as clomiphene citrate by COSETTE on August 30th, 1999.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CLOMIPHENE CITRATE?
  • What are the global sales for CLOMIPHENE CITRATE?
  • What is Average Wholesale Price for CLOMIPHENE CITRATE?
Summary for CLOMIPHENE CITRATE
Drug patent expirations by year for CLOMIPHENE CITRATE
Drug Prices for CLOMIPHENE CITRATE

See drug prices for CLOMIPHENE CITRATE

Recent Clinical Trials for CLOMIPHENE CITRATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Batterjee Medical CollegePhase 4
Bezmialem Vakif UniversityN/A
Johns Hopkins UniversityPhase 3

See all CLOMIPHENE CITRATE clinical trials

Pharmacology for CLOMIPHENE CITRATE
Medical Subject Heading (MeSH) Categories for CLOMIPHENE CITRATE

US Patents and Regulatory Information for CLOMIPHENE CITRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cosette CLOMIPHENE CITRATE clomiphene citrate TABLET;ORAL 075528-001 Aug 30, 1999 RX No Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

CLOMIPHENE CITRATE Market Analysis and Financial Projection Experimental

Clomiphene Citrate Market Dynamics and Financial Trajectory

Market Overview

Clomiphene citrate, commonly known by the brand name Clomid, is a non-steroidal fertility medication used primarily for ovulation induction in women with infertility issues. The global market for clomiphene citrate has been experiencing significant growth, driven by several key factors.

Market Size and Growth Projections

As of 2023, the global clomiphene citrate market was valued at USD 1,231.82 million. It is projected to grow to USD 1,780.04 million by 2030, with a Compounded Annual Growth Rate (CAGR) of 5.4%[3].

Drivers of Market Growth

Increasing Infertility Rates

The rising prevalence of infertility worldwide is a major driver of the clomiphene citrate market. Factors such as delayed parenthood, lifestyle changes, and increasing awareness about fertility treatments contribute to this trend[3][4].

Advancements in Assisted Reproductive Technologies (ART)

Advancements in ART and the growing acceptance of fertility treatments are boosting the demand for clomiphene citrate. This includes improvements in healthcare infrastructure and the expansion of fertility clinics globally[3][4].

Government Initiatives and Regulatory Support

Favorable government initiatives aimed at promoting fertility treatments and improving access to reproductive healthcare further propel market expansion. These initiatives help in increasing the accessibility and affordability of fertility treatments[3].

Regional Analysis

Developed Markets

Regions such as North America and Europe account for a significant share of the market, driven by higher healthcare spending and greater awareness about fertility treatments. These markets are characterized by well-established healthcare infrastructures and high demand for fertility services[4].

Emerging Markets

The Asia Pacific, Latin America, and Middle East regions present lucrative growth opportunities due to rising infertility rates, increasing disposable income, and improving access to healthcare facilities. These regions are witnessing a surge in demand for assisted reproductive technologies, further boosting market growth[3][4].

Market Dynamics

Drivers

  • Increasing Infertility Rates: Rising infertility issues globally drive the demand for clomiphene citrate.
  • Advancements in ART: Improvements in reproductive technologies enhance the effectiveness and appeal of fertility treatments.
  • Government Support: Favorable government initiatives promote fertility treatments and improve access to reproductive healthcare[3][4].

Restraints

  • Regulatory Challenges: Regulatory complexities and varying regulatory frameworks across regions can pose constraints to market growth.
  • Cultural Barriers: Cultural attitudes toward fertility treatments can affect market penetration in certain regions.
  • Safety Concerns: Potential side effects and adverse perinatal outcomes associated with clomiphene citrate use may impact market growth[3][5].

Opportunities

  • Untapped Markets: Regions like the Middle East, Africa, and Latin America offer untapped opportunities due to evolving healthcare landscapes and expanding fertility clinics.
  • Research and Development: Continuous R&D activities focused on enhancing treatment outcomes and reducing side effects can drive market expansion[3][4].

Challenges

  • Alternative Treatments: The emergence of alternative fertility treatments may pose competition to clomiphene citrate.
  • Safety and Efficacy: Ensuring the safety and efficacy of clomiphene citrate, especially in terms of fetal development and pregnancy outcomes, is a critical challenge[5].

Competitive Landscape

The clomiphene citrate market is highly competitive, with several pharmaceutical companies offering both generic and branded formulations. Key players focus on product differentiation, market expansion, and strategic collaborations to gain a competitive edge. Investments in R&D to develop novel drug delivery formulations and improve treatment outcomes are also a priority[4].

Cost and Affordability

Clomiphene citrate is generally considered affordable, with costs ranging from about $10 to $100 per cycle, depending on the dose and whether a brand name or generic version is used. The average cost for a cycle of Clomid is approximately $40, while generic clomiphene citrate can cost around $15 per cycle[2].

Future Outlook

The future outlook for the clomiphene citrate market is promising, driven by increasing infertility rates, technological advancements in reproductive medicine, and expanding access to fertility treatments worldwide. Despite regulatory and safety challenges, strategic initiatives focused on innovation, patient-centric care, and regulatory compliance are expected to drive market growth and differentiation[4].

Key Takeaways

  • The global clomiphene citrate market is projected to grow significantly, driven by increasing infertility rates and advancements in ART.
  • Emerging markets in Asia Pacific, Latin America, and the Middle East offer lucrative growth opportunities.
  • Regulatory challenges and safety concerns must be addressed to ensure sustainable market growth.
  • Continuous R&D and strategic collaborations are crucial for market players to maintain competitiveness.
  • The market is expected to expand due to favorable government initiatives and improving healthcare infrastructure.

FAQs

Q: What is the current market size of the global clomiphene citrate market?

A: As of 2023, the global clomiphene citrate market was valued at USD 1,231.82 million[3].

Q: What is the projected growth rate of the clomiphene citrate market?

A: The market is expected to grow at a CAGR of 5.4% from 2023 to 2030[3].

Q: What are the main drivers of the clomiphene citrate market?

A: The main drivers include increasing infertility rates, advancements in ART, and favorable government initiatives[3][4].

Q: Which regions offer the most promising growth opportunities for clomiphene citrate?

A: Emerging markets in Asia Pacific, Latin America, and the Middle East offer significant growth prospects due to rising infertility rates and improving healthcare access[3][4].

Q: What are the potential challenges facing the clomiphene citrate market?

A: Regulatory challenges, cultural barriers, and safety concerns related to adverse perinatal outcomes are potential challenges[3][5].

Sources

  1. Market Research Intellect: Global Clomiphene Citrate Market Size, Trends and Projections.
  2. Advanced Fertility: Clomid Fertility Drug Treatment Protocols, Clomiphene Citrate.
  3. Reanin: Clomiphene Citrate Market | Growth | Size | Trends and Forecast.
  4. MarkWide Research: Clomiphene Citrate Market 2024-2032 | Size, Share, Growth.
  5. Oxford Academic: Clomiphene Citrate Administered in Periconception Phase Causes ...

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.